DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews
Sage Therapeutics, Inc. found using ticker (SAGE) now have 18 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low ...
Read Article »Home » EPIC Archives: SAGE
SAGE News Archives
[wpw_follow_term_me posttype="post" taxonomy="post_tag" termid="1440"][/wpw_follow_term_me]
Sage Therapeutics, Inc. – Consenus Indicates Potential 34.4% Upside
Sage Therapeutics, Inc. with ticker code (SAGE) have now 18 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 24.5% Upside
Sage Therapeutics, Inc. found using ticker (SAGE) have now 18 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 18.5% Upside
Sage Therapeutics, Inc. found using ticker (SAGE) now have 18 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 250 and 90 with ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 21.7% Upside
Sage Therapeutics, Inc. with ticker code (SAGE) now have 18 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 250 and 90 ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 21.7% Upside
Sage Therapeutics, Inc. with ticker code (SAGE) now have 18 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 250 and 90 ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 23.2% Upside
Sage Therapeutics, Inc. found using ticker (SAGE) have now 18 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 22.7% Upside
Sage Therapeutics, Inc. with ticker code (SAGE) have now 18 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 17.4% Upside
Sage Therapeutics, Inc. with ticker code (SAGE) have now 18 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price ...
Read Article »Sage Therapeutics, Inc. – Consenus Indicates Potential 26.3% Upside
Sage Therapeutics, Inc. found using ticker (SAGE) have now 18 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price ...
Read Article »